AmorChem II Overview
- Fund Type
-
Venture
- Fund Status
-
Closed
- Fund Manager
- GeneChem
- (You're viewing 1 of 2)
- Size
-
- Vintage
-
2018
- Dry Powder
-
AmorChem II General Information
Description
AmorChem II is a 2018 vintage venture capital fund co-managed by GeneChem and AmorChem. The fund is located in Westmount, Quebec and will invest in Quebec. The fund targets pharmaceuticals and biotechnology and life sciences sectors.
Contact Information
Fund Manager's Location
- 4, Westmount Square
- Suite 160
- Westmount, Quebec H3Z 2S6
- Canada
AmorChem II Investments (7)
AmorChem II has made a total of 7 investments. Its most recent deal was a with Giiant Pharma for . The deal was made on 30-Jun-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Giiant Pharma | 30-Jun-2021 | Drug Discovery | Pre-Clinical Trials | |||
| Inversago Pharma | 08-Sep-2020 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Neurasic Therapeutics | 25-Mar-2020 | Drug Discovery | Generating Revenue | |||
| MyX Therapeutics | 09-Oct-2018 | Drug Delivery | Startup | |||
| Inversago Pharma | 25-Jul-2018 | Drug Discovery | Pre-Clinical Trials | |||
| SemaThera | 21-Mar-2018 | Early Stage VC | Biotechnology | Startup | ||
| SpecificiT Pharma | 23-Aug-2017 | Seed Round | Biotechnology | Startup |
AmorChem II Investment Strategy
Investments by Industry
Investments by Deal Type
AmorChem II Limited Partners (4)
Fondaction is one of AmorChem II’s 4 limited partners. Its latest Original was on 31-Dec-2018.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| Fondaction | Current | 31-Dec-2018 | Original | ||
| Fonds de solidarite FTQ | Current | 31-Dec-2018 | Original | ||
| Merck | Current | 31-Dec-2018 | Original | ||
| Government of Quebec | Government Agency | Current | 23-Mar-2016 | Original |
AmorChem II Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
AmorChem II Benchmark (583)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| Foundry.ai Fund I | |||||
| BioStar Ventures III-XF | 31-Dec-2024 | ||||
| Collab + Currency | 31-Mar-2024 | ||||
| LifeSci Venture Partners I | |||||
| BAM Ventures Partners II | |||||
| Wavemaker Partners V | |||||
| Yield Lab II | |||||
| LaunchTennessee Impact Fund | |||||
| New Ventures I | |||||
| EOS Global Fund |
AmorChem II FAQs
-
What is AmorChem II?
AmorChem II is a 2018 vintage venture capital fund co-managed by GeneChem and AmorChem.
-
Who manages AmorChem II?
-
Where is AmorChem II domiciled?
AmorChem II is domiciled in Canada.
-
What is AmorChem II's size?
AmorChem II has a size of .
-
What type of fund is AmorChem II?
The fund type of AmorChem II is Venture.
-
What is the status of AmorChem II?
AmorChem II is closed.
-
What has AmorChem II invested in?
AmorChem II has made numerous investments in companies like Giiant Pharma, Inversago Pharma, and Neurasic Therapeutics within the Drug Discovery industry.
-
What has AmorChem II invested in recently?
AmorChem II's latest investment was on 30-Jun-2021 in Giiant Pharma, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
